The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Yoshinobu Kanda

Division of Hematology

Saitama Medical Center

Jichi Medical University

Saitama

Japan

[email]@umin.ac.jp

Name/email consistency: medium

 
 
 
 
 
 
 

Affiliations

  • Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan. 2008 - 2013
  • Department of Cell Therapy and Transplantation Medicine, University of Tokyo Hospital, Japan. 2004 - 2006
  • Department of Hematology, International Medical Center of Japan, Tokyo. 2000 - 2001

References

  1. In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation. Kanda, Y., Oshima, K., Kako, S., Fukuda, T., Uchida, N., Miyamura, K., Kondo, Y., Nakao, S., Nagafuji, K., Miyamoto, T., Kurokawa, M., Okoshi, Y., Chiba, S., Ohashi, Y., Takaue, Y., Taniguchi, S. Am. J. Hematol. (2013) [Pubmed]
  2. A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT. Kanda, Y., Yamashita, T., Mori, T., Ito, T., Tajika, K., Mori, S., Sakura, T., Hara, M., Mitani, K., Kurokawa, M., Akashi, K., Harada, M. Bone Marrow Transplant. (2010) [Pubmed]
  3. Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese survey. Kanda, Y., Omuro, Y., Baba, E., Oshima, K., Nagafuji, K., Heike, Y., Takaue, Y., Sasaki, T., Sakamaki, H., Harada, M. Bone Marrow Transplant. (2008) [Pubmed]
  4. Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: does body weight matter? Kanda, Y., Okamoto, S., Tauchi, T., Kizaki, M., Inokuchi, K., Yabe, M., Yokoyama, K., Ito, Y., Kimura, Y., Higashihara, M., Bessho, M., Ando, K., Chiba, S., Kurokawa, M., Oshimi, K., Dan, K., Ohyashiki, K., Ikeda, Y. Am. J. Hematol. (2008) [Pubmed]
  5. Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor. Kanda, Y., Hyo, R., Yamashita, T., Fujimaki, K., Oshima, K., Onoda, M., Mori, T., Sakura, T., Tanaka, M., Sakai, M., Taguchi, J., Kurakawa, M., Maruta, A., Okamoto, S., Sakamaki, H. Am. J. Hematol. (2006) [Pubmed]
  6. In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation. Kanda, Y., Oshima, K., Asano-Mori, Y., Kandabashi, K., Nakagawa, M., Sakata-Yanagimoto, M., Izutsu, K., Hangaishi, A., Tsujino, S., Ogawa, S., Motokura, T., Chiba, S., Hirai, H. Transplantation (2005) [Pubmed]
  7. Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor. Kanda, Y., Sakamaki, H., Sao, H., Okamoto, S., Kodera, Y., Tanosaki, R., Kasai, M., Hiraoka, A., Takahashi, S., Miyawaki, S., Kawase, T., Morishima, Y., Kato, S. Biol. Blood Marrow Transplant. (2005) [Pubmed]
  8. Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate. Kanda, Y., Izutsu, K., Hirai, H., Sakamaki, H., Iseki, T., Kodera, Y., Okamoto, S., Mitsui, H., Iwato, K., Hirabayashi, N., Furukawa, T., Maruta, A., Kasai, M., Atsuta, Y., Hamajima, N., Hiraoka, A., Kawa, K. Leukemia (2004) [Pubmed]
  9. Lack of correlation between clinical characteristics and serum soluble Fas ligand levels in patients with multiple myeloma. Kanda, Y., Ara, C., Chizuka, A., Yamamoto, R., Hamaki, T., Suguro, M., Matsuyama, T., Takezako, N., Miwa, A., Tohma, J., Shirakawa, K., Yatomi, T., Nakamura, N., Hirai, H., Togawa, A. Leuk. Lymphoma (2001) [Pubmed]
  10. Pyogenic granuloma of the tongue early after allogeneic bone marrow transplantation for multiple myeloma. Kanda, Y., Arai, C., Chizuka, A., Suguro, M., Hamaki, T., Yamamoto, R., Yamauchi, Y., Matsuyama, T., Takezako, N., Shirai, Y., Miwa, A., Iwasaki, K., Nasu, M., Togawa, A. Leuk. Lymphoma (2000) [Pubmed]
  11. Treatment of deep vein thrombosis using temporary vena caval filters after allogeneic bone marrow transplantation. Kanda, Y., Yamamoto, R., Chizuka, A., Suguro, M., Hamaki, T., Matsuyama, T., Takezako, N., Miwa, A., Togawa, A., Kume, M., Tsukuda, M., Hasuo, K. Leuk. Lymphoma (2000) [Pubmed]
  12. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials. Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., Kami, M., Akiyama, H., Hirai, H., Togawa, A. Cancer (2000) [Pubmed]
 
WikiGenes - Universities